Mark J Rosenblum - Net Worth and Insider Trading
Mark J Rosenblum Net Worth
The estimated net worth of Mark J Rosenblum is at least $2,795 dollars as of 2024-05-22. Mark J Rosenblum is the Exec VP Finance, CFO of Salarius Pharmaceuticals Inc and owns about 5,933 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $2,794. Mark J Rosenblum is also the CFO of Advaxis Inc and owns about 2 shares of Advaxis Inc (ADXS) stock worth over $1. Details can be seen in Mark J Rosenblum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark J Rosenblum has not made any transactions after 2022-05-31 and currently still holds the listed stock(s).
Transaction Summary of Mark J Rosenblum
Mark J Rosenblum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J Rosenblum owns 3 companies in total, including Salarius Pharmaceuticals Inc (SLRX) , ActiveCare Inc (ACARQ) , and Advaxis Inc (ADXS) .
Click here to see the complete history of Mark J Rosenblum’s form 4 insider trades.
Insider Ownership Summary of Mark J Rosenblum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-05-31 | Exec VP Finance & Interim CFO |
| ACARQ | ActiveCare Inc | 2017-12-11 | director & Chief Executive Officer |
| ADXS | Advaxis Inc | 2013-10-24 | Chief Financial Officer |
Mark J Rosenblum Latest Holdings Summary
Mark J Rosenblum currently owns a total of 2 stocks. Among these stocks, Mark J Rosenblum owns 5,933 shares of Salarius Pharmaceuticals Inc (SLRX) as of May 31, 2022, with a value of $2,794 and a weighting of 99.98%. Mark J Rosenblum also owns 2 shares of Advaxis Inc (ADXS) as of October 24, 2013, with a value of $1 and a weighting of 0.02%.
Latest Holdings of Mark J Rosenblum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-05-31 | 5,933 | 0.47 | 2,794 |
| ADXS | Advaxis Inc | 2013-10-24 | 2 | 0.30 | 1 |
Holding Weightings of Mark J Rosenblum
Mark J Rosenblum Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J Rosenblum has made a total of 5 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 1,120 shares on May 31, 2022, which cost Mark J Rosenblum around $5,040.
According to the SEC Form 4 filings, Mark J Rosenblum has made a total of 0 transactions in Advaxis Inc (ADXS) over the past 5 years. The most-recent trade in Advaxis Inc is the acquisition of 10 shares on October 24, 2013, which cost Mark J Rosenblum around $48,000.
Insider Trading History of Mark J Rosenblum
- 1
Mark J Rosenblum Trading Performance
GuruFocus tracks the stock performance after each of Mark J Rosenblum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark J Rosenblum is -1.22%. GuruFocus also compares Mark J Rosenblum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark J Rosenblum within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark J Rosenblum's insider trading performs compared to the benchmark.
Performance of Mark J Rosenblum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.19 | | | | | |
| Relative Return to S&P 500(%) | 2.05 | | | | | |
Mark J Rosenblum Ownership Network
Mark J Rosenblum Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Mark J Rosenblum is the Exec VP Finance & Interim CFO of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include director & Chief Executive Officer David J. Arthur , Chief Financial Officer Scott Jordan , and Controller Pao-yu Chuang .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Mark J Rosenblum Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J Rosenblum. You might contact Mark J Rosenblum via mailing address: 3990 Spring Valley Road, Apt. 1218, Dallas Tx 75244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
